Discovery of (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid Hydrochloride (GAP-134)13, an Orally Active Small Molecule Gap-Junction Modifier for the Treatment of Atrial Fibrillation.
| Autor: | John A. Butera, Bjarne Due Larsen, James K. Hennan, Edward Kerns, Li Di, Asaf Alimardanov, Robert E. Swillo, Gwen A. Morgan, Kun Liu, Qiang Wang, Eric I. Rossman, Rayomand Unwalla, Leonard McDonald, Christine Huselton, Jørgen S. Petersen |
|---|---|
| Zdroj: | Journal of Medicinal Chemistry; Feb2009, Vol. 52 Issue 4, p908-911, 4p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|